Manuel D Gahete

25PUBLICATIONS
40CO-AUTHORS
Molecular targetsPharmacogenomicsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 13, 2025
Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer.

Francisco Porcel-Pastrana, Antonio J Montero-Hidalgo, Miguel E G-García

|Feb 05, 2025
From pituitary cells to prostate gland in health and disease: direct and indirect endocrine connections.

André Sarmento-Cabral, Antonio C Fuentes-Fayos, Fernando Mata Ordoñez

|Dec 26, 2024
The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.

Natalia Hermán-Sánchez, Miguel E G-García, Juan M Jiménez-Vacas

|Oct 02, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.

Antonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez

|Sep 04, 2024
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.

Ricardo Blázquez-Encinas, Emilia Alors-Pérez, María Trinidad Moreno-Montilla

|May 25, 2024
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.

Emilia Alors-Pérez, Ricardo Blázquez-Encinas, María Trinidad Moreno-Montilla

Pageof 5